Merck, N5285-25G, Neomycin trisulfate salt hydrate

General description
Chemical structure: aminoglycoside
Stock solutions should be filter sterilized and stored at 2-8 °C. Stable at 37 °C for 5 days.
Application
Neomycin Trisulfate is produced by Streptomyces containing a minimum of 85% neomycin B. It has been used as a selection agent for prokaryotic cells transformed using the neo selectable marker gene, and to study ototoxic side effects of antibiotics, platelet-derived growth factor responses in certain fibroblasts, and extraction of Nuclear Phosphatidylinositol 4,5-Bisphosphate-Interacting Proteins. It is recommended for use in cell culture applications at 50 mg/L.
Biochem/physiol Actions
Mode of action: This product acts by binding to the 30S and 50S subunits, causing miscoding and inhibiting initiation and elongation during protein synthesis. Neomycin also blocks voltage-sensitive Ca²⁺ channels without affecting the Na⁺/Ca²⁺ antiporter in neurons.

Antimicrobial spectrum: Neomycin acts against both gram-positive and gram-negative bacteria.
Preparation Note
Neomycin sulfate is soluble in H₂O at 50 mg/mL, yielding a clear solution.
Other Notes
Keep container tightly closed in a dry and well-ventilated place.Keep in a dry place
Disclaimer
Stock solutions should be filter sterilized and stored at 2-8°C, and are stable at 37°C for 5 days. A 1 mg/mL neomycin solution in .1 M phosphate buffer, pH 8.0 should be used within 14 days when stored at 0-5°C. Solutions should be protected from light or moisture.